Perfect Medical Industry Co., Ltd. (TPEX:6543)
Taiwan
· Delayed Price · Currency is TWD 22.95
+0.30 (1.32%)
Apr 29, 2026, 1:17 PM CST
Perfect Medical Industry Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 54.25 | 89.12 | 40.09 | 14.27 | 38.77 | Upgrade
|
| Depreciation & Amortization | 67.44 | 56.27 | 56.86 | 55.78 | 48.4 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.02 | -0.4 | -1.19 | -1.18 | -0.19 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 4.28 | 14.61 | - | - | Upgrade
|
| Stock-Based Compensation | 1.25 | 4.52 | 3.17 | 0.03 | - | Upgrade
|
| Provision & Write-off of Bad Debts | -0.09 | 0.09 | 0.01 | 0.02 | 0.26 | Upgrade
|
| Other Operating Activities | -4.83 | -9.75 | 11.71 | 3.82 | 3.98 | Upgrade
|
| Change in Accounts Receivable | -17.7 | 4.17 | -2.38 | -2.37 | -3.7 | Upgrade
|
| Change in Inventory | 5.08 | -25.15 | 14.21 | 47.83 | -73.02 | Upgrade
|
| Change in Accounts Payable | 3.17 | 9.08 | 3.15 | -9.62 | -13.3 | Upgrade
|
| Change in Unearned Revenue | 13.8 | -1.09 | -1.46 | 1.05 | 1.56 | Upgrade
|
| Change in Other Net Operating Assets | -14.75 | 12.4 | 11.09 | -4.02 | 1.68 | Upgrade
|
| Operating Cash Flow | 107.62 | 143.54 | 149.87 | 105.61 | 4.44 | Upgrade
|
| Operating Cash Flow Growth | -25.02% | -4.22% | 41.91% | 2277.07% | -96.24% | Upgrade
|
| Capital Expenditures | -196.08 | -96.98 | -64.7 | -52.75 | -103.34 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.65 | 6.98 | 13.1 | 5.88 | 2.42 | Upgrade
|
| Sale (Purchase) of Intangibles | -2.86 | -1.54 | -1.61 | - | -0.24 | Upgrade
|
| Investment in Securities | 29.79 | -12.85 | -19.01 | - | 48.09 | Upgrade
|
| Other Investing Activities | -24.59 | -6.12 | 8.64 | 2.48 | -8.77 | Upgrade
|
| Investing Cash Flow | -191.09 | -110.5 | -63.57 | -44.39 | -61.84 | Upgrade
|
| Short-Term Debt Issued | 541.1 | 130 | 280 | 545.13 | 563.62 | Upgrade
|
| Long-Term Debt Issued | 126 | 1,231 | 1,447 | 93 | - | Upgrade
|
| Total Debt Issued | 667.1 | 1,361 | 1,727 | 638.13 | 563.62 | Upgrade
|
| Short-Term Debt Repaid | -391.22 | -210 | -234.67 | -717.68 | -423.25 | Upgrade
|
| Long-Term Debt Repaid | -115.49 | -1,180 | -1,491 | -37.16 | -27.71 | Upgrade
|
| Total Debt Repaid | -506.72 | -1,390 | -1,726 | -754.83 | -450.96 | Upgrade
|
| Net Debt Issued (Repaid) | 160.39 | -29.26 | 0.49 | -116.71 | 112.66 | Upgrade
|
| Issuance of Common Stock | 48.2 | 107.87 | - | 45.6 | 27.89 | Upgrade
|
| Common Dividends Paid | -45.82 | -65.14 | -16.9 | -14.43 | -58.77 | Upgrade
|
| Other Financing Activities | 0.4 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 163.17 | 13.47 | -16.4 | -85.54 | 81.77 | Upgrade
|
| Foreign Exchange Rate Adjustments | -21.48 | -0.75 | -1.24 | -2.19 | -0.01 | Upgrade
|
| Net Cash Flow | 58.21 | 45.77 | 68.67 | -26.5 | 24.37 | Upgrade
|
| Free Cash Flow | -88.46 | 46.56 | 85.17 | 52.87 | -98.89 | Upgrade
|
| Free Cash Flow Growth | - | -45.33% | 61.11% | - | - | Upgrade
|
| Free Cash Flow Margin | -11.36% | 6.26% | 11.60% | 7.81% | -13.65% | Upgrade
|
| Free Cash Flow Per Share | -1.54 | 0.91 | 1.85 | 1.20 | -2.43 | Upgrade
|
| Cash Interest Paid | 6.71 | 3.53 | 4.32 | 4.35 | 2.76 | Upgrade
|
| Cash Income Tax Paid | 17.16 | 20 | 12.13 | 20.38 | 23.76 | Upgrade
|
| Levered Free Cash Flow | -125.94 | 3.12 | 71.03 | 33.96 | -104.18 | Upgrade
|
| Unlevered Free Cash Flow | -121.67 | 5.45 | 73.76 | 36.74 | -102.33 | Upgrade
|
| Change in Working Capital | -10.4 | -0.59 | 24.61 | 32.88 | -86.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.